Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial
For patients diagnosed with a significant vitamin B12 deficiency, our healthcare team typically begins treatment with more frequent injections, often weekly or even more often, until healthy vitamin B12 levels are restored
Novinscak T, Brcic L, Staresinic M, Jukic I, Radic B, Pevec D, Mise S, Tomasovic S, Brcic I, Banic T, Jakir A, Buljat G, Anic T, Zoricic I, Romic Z, Seiwerth S, Sikiric P
F) Bar graph representing the percent correlation of treatment-induced postsynaptic spines to the postsynaptic marker PSD-95